Non-sexual HPV transmission and role of vaccination for a better future (Review).
Gardasil 9
HPV related disease
HPV transmission routes
HPV vaccination
human papillomavirus
Journal
Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
06
07
2020
accepted:
05
08
2020
entrez:
26
10
2020
pubmed:
27
10
2020
medline:
27
10
2020
Statut:
ppublish
Résumé
Human papilloma viruses (HPVs) belong to the Papillomaviridae family and are epitheliotropic infecting squamous epithelia (skin and mucosae). HPV is estimated to be the cause of 99% of cervical cancers (there is no evidence of significant genetic predisposition for cervical cancer), 90% of anal cancer, 65% vaginal cancers, 50% vulvar cancers, and 45-90% oropharyngeal cancers. The route of HPV transmission is primarily through skin-to-skin or skin-to-mucosa contact. Sexual transmission is the most documented, but there have been studies suggesting non-sexual courses. The horizontal transfer of HPV includes fomites, fingers, and mouth, skin contact (other than sexual). Self-inoculation is described in studies as a potential HPV transmission route, as it was certified in female virgins, and in children with genital warts (low-risk HPV) without a personal history of sexual abuse. Vertical transmission from mother to child is another HPV transfer course. Several studies have emphasized the possibility of infection through the amniotic fluid, or the placenta, or via contact with maternal genital mucosa during natural birth. Waterborne transmission of HPV has never been demonstrated; however, HPV DNA has been detected in water environments. Routine hygiene measures are proven to be inefficient in preventing HPV transmission, as the studies which have evaluated samples of HPV on contaminated medical equipment (after standard disinfection) have found them to be still positive. Annual costs associated with the morbidity and mortality of HPV-related diseases are estimated at approximately $4 billion. Once the HPV vaccine program in Australia was launched, many studies reported the initial effects: A decrease in the incidence of high-grade cervical abnormalities, no new genital warts cases in females under 21 years. Promoting greater understanding in the general public about the evident benefits of vaccination can create positive vaccine attitudes and scatter the myths of spurious side effects.
Identifiants
pubmed: 33101476
doi: 10.3892/etm.2020.9316
pii: ETM-0-0-09316
pmc: PMC7579832
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
186Informations de copyright
Copyright © 2020, Spandidos Publications.
Références
Sex Transm Infect. 2016 Feb;92(1):19-23
pubmed: 26071392
Vaccine. 2011 Oct 26;29(46):8443-50
pubmed: 21816193
Environ Sci Technol. 2013 Feb 19;47(4):1945-51
pubmed: 23346855
Cancer Causes Control. 2015 Jun;26(6):953-4
pubmed: 25804857
Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S849-55
pubmed: 26602622
Aust N Z J Obstet Gynaecol. 1990 Aug;30(3):240-2
pubmed: 2256864
J Otolaryngol Head Neck Surg. 2013 Nov 18;42:54
pubmed: 24246045
BMC Infect Dis. 2013 Feb 27;13:109
pubmed: 23446269
Clin Dermatol. 2014 Mar-Apr;32(2):299-306
pubmed: 24559567
Lancet. 2011 Jun 18;377(9783):2085-92
pubmed: 21684381
JAMA. 2014 Oct 8;312(14):1465-7
pubmed: 25291584
Food Environ Virol. 2014 Mar;6(1):1-12
pubmed: 24293168
Med J Aust. 2017 Apr 3;206(6):262
pubmed: 28359009
Exp Ther Med. 2019 Jun;17(6):4337-4343
pubmed: 31186676
Food Environ Virol. 2015 Dec;7(4):309-15
pubmed: 26049729
JAMA. 2011 Oct 19;306(15):1699-700
pubmed: 21979129
Oncol Lett. 2016 Sep;12(3):1779-1782
pubmed: 27602111
Exp Ther Med. 2018 Jan;15(1):412-418
pubmed: 29375696
Lancet Infect Dis. 2011 Jan;11(1):39-44
pubmed: 21067976
J Gen Virol. 2015 Mar;96(Pt 3):607-613
pubmed: 25398789
Emerg Med J. 2013 Jun;30(6):472-5
pubmed: 22761513
PLoS One. 2012;7(10):e48137
pubmed: 23110191
Prev Med. 2011 Oct;53 Suppl 1:S29-35
pubmed: 21962468
Gynecol Oncol. 2011 Apr;121(1):148-51
pubmed: 21208649
Expert Rev Anti Infect Ther. 2014 Oct;12(10):1165-70
pubmed: 25199987
Epidemiol Infect. 2016 Feb;144(3):449-68
pubmed: 26429676
Sex Transm Infect. 2015 May;91(3):214-9
pubmed: 25305210
Int J Oncol. 2018 Mar;52(3):637-655
pubmed: 29393378